Cy Dex Pharmaceuticals
Pharmaceuticals, W 84th Ter, Lenexa, , 66214, Kansas, 10513, United States, 11-50 Employees
Phone Number: +19*********
Who is CYDEX PHARMACEUTICALS
CyDex Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of drugs specifically designed to address limitations of current therapi...
Read More
-
Headquarters: 10513 W 84th Ter, Lenexa, Kansas, 66214, United States
-
Employees: 11-50
-
Revenue: $10 Million to $25 Million
Industry: Pharmaceuticals
SIC Code: 5122
|
NAICS Code: 424210 |
Show More
Does something look wrong? Fix it. | View contact records from CYDEX PHARMACEUTICALS
CyDex Pharmaceuticals Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding CyDex Pharmaceuticals
Answer: CyDex Pharmaceuticals's headquarters are located at W 84th Ter, Lenexa, , 66214, Kansas, 10513, United States
Answer: CyDex Pharmaceuticals's phone number is +19*********
Answer: CyDex Pharmaceuticals's official website is https://cydexpharma.com
Answer: CyDex Pharmaceuticals's revenue is $10 Million to $25 Million
Answer: CyDex Pharmaceuticals's SIC: 5122
Answer: CyDex Pharmaceuticals's NAICS: 424210
Answer: CyDex Pharmaceuticals has 11-50 employees
Answer: CyDex Pharmaceuticals is in Pharmaceuticals
Answer: CyDex Pharmaceuticals contact info: Phone number: +19********* Website: https://cydexpharma.com
Answer: CyDex Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of drugs specifically designed to address limitations of current therapies in selected established markets. We have developed a portfolio of product candidates utilizing our drug formulation technology using Captisol cyclodextrins. Captisol cyclodextrins are a patent protected, specifically modified family of cyclodextrins designed to improve solubility, stability, bioavailability, safety and/or dosing of a number of active pharmaceutical ingredients, or APIs. In order to maximize our internal resources, experience and technology, we are focusing on the development and commercialization of product candidates for use in the acute care hospital setting. For those product candidates that likely will entail more extensive development and commercialization efforts, we partner with established pharmaceutical or specialty pharmaceutical companies. We also outlicense our Captisol technology to third parties for use in the development of their own products. CyDex was acquired by Ligand Pharmaceuticals, Inc. in January 2011.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month